Annuncio • Jun 03
Rapid Nutrition Expands Agentic AI Integration Across Consumer Wellness Ecosystem Rapid Nutrition PLC has progressively expanded the rollout of its technology-enabled engagement platform across investor communications, consumer wellness interactions and broader digital operations as part of its strategy to build a scalable HealthTech ecosystem at the intersection of nutrition, technology and consumer behaviour. Following the initial deployment across investor communications, Rapid Nutrition has observed improved accessibility and responsiveness, with investor enquiries increasingly being addressed in near real-time across multiple time zones. The Company has since expanded the platform across elements of its consumer ecosystem, including the Company’s flagship SystemLS brand, where early-stage engagement trends indicate increasing interaction with product, wellness and lifestyle-aligned content tailored to individual user interests and behaviours. Rapid Nutrition believes the application of artificial intelligence and agentic capabilities enables a transition from static information delivery toward more responsive, real-time and personalized engagement across both investor and consumer channels. The platform has been developed using Company materials and operational frameworks and continues to be refined by Rapid Nutrition’s experienced team to ensure alignment with the Company’s products, communication standards and broader wellness ecosystem. Annuncio • May 13
Rapid Nutrition plc Expands AI-Powered Agentic Platform to Consumer Ecosystem Rapid Nutrition PLC announced the expansion of its technology platform to its consumer-facing ecosystem, following a successful rollout within its investor communications infrastructure. The Company is extending these capabilities across its flagship SystemLS brand, enabling a more responsive and personalized approach to consumer health and wellness engagement. The platform delivers structured, on-demand guidance across nutrition, products, and lifestyle — available 24/7 in a private, confidential environment. As consumer expectations increasingly flavor personalized health solutions, the system is designed to translate product and nutritional information into practical, everyday guidance aligned to individual habits and routines. Trained on Company materials and informed by Rapid Nutrition’s experienced team, the platform ensures all responses reflect the Company’s product philosophy, nutritional methodologies, and established wellness programs. The system is designed to complement, not replace, professional human interaction — extending access to practitioner-informed guidance while maintaining alignment with the Company’s personalised nutrition approach. It supports consumer education only and does not constitute professional medical advice. This expansion represents a continued step in Rapid Nutrition’s strategy to deploy advanced technologies — including artificial intelligence and agentic capabilities — across both its corporate and consumer operations, driving deeper and more consistent engagement with long-term wellness programs. Reported Earnings • Apr 30
Full year 2025 earnings released: AU$0.01 loss per share (vs AU$38.10 loss in FY 2024) Full year 2025 results: AU$0.01 loss per share. Net loss: AU$3.10m (loss widened 6.8% from FY 2024). Annuncio • Apr 22
Rapid Nutrition PLC (ENXTPA:ALRPD) agreed to acquire Health and wellness retail locations in Australia. Rapid Nutrition PLC (ENXTPA:ALRPD) agreed to acquire Health and wellness retail locations in Australia on April 20, 2026.
The transaction is subject to consummation of due diligence investigation and final documentation. Board Change • Apr 13
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 2 highly experienced directors. 1 independent director (2 non-independent directors). Independent Non-Executive Director Shayne Kellow was the last independent director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Buy Or Sell Opportunity • Feb 10
Now 29% undervalued Over the last 90 days, the stock has risen 237% to €10.12. The fair value is estimated to be €14.25, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Buy Or Sell Opportunity • Jan 22
Now 35,009% overvalued after recent price rise Over the last 90 days, the stock has risen 124,224% to €4.60. The fair value is estimated to be €0.013, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 41% over the last 3 years. Meanwhile, the company became loss making. Annuncio • Jan 05
Rapid Nutrition PLC announced that it has received €5 million in funding Rapid Nutrition PLC announced a private placement of common shares for gross proceeds of €5 million on January 5, 2026. Reported Earnings • Oct 29
First half 2025 earnings released: EPS: AU$0 (vs AU$0 in 1H 2024) First half 2025 results: EPS: AU$0 (in line with 1H 2024). Revenue: AU$113.1k (down 59% from 1H 2024). Net loss: AU$1.65m (loss narrowed 17% from 1H 2024). Revenue is forecast to grow 32% p.a. on average during the next 3 years, compared to a 3.9% growth forecast for the Personal Products industry in Europe. New Risk • Oct 17
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 17% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 7x increase in shares outstanding). Revenue is less than US$1m (AU$917k revenue, or US$594k). Market cap is less than US$10m (€2.14m market cap, or US$2.50m). Minor Risks Latest financial reports are more than 6 months old (reported December 2024 fiscal period end). Share price has been volatile over the past 3 months (9.7% average weekly change). New Risk • Dec 13
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$2.9m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$2.9m free cash flow). Share price has been highly volatile over the past 3 months (41% average weekly change). Earnings have declined by 34% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 18x increase in shares outstanding). Revenue is less than US$1m (AU$1.3m revenue, or US$816k). Market cap is less than US$10m (€3.19m market cap, or US$3.35m). Reported Earnings • Oct 24
First half 2024 earnings released First half 2024 results: EPS: AU$0. Revenue: AU$276.1k (down 58% from 1H 2023). Net loss: AU$1.99m (loss widened 117% from 1H 2023). Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Personal Products industry in Europe. Reported Earnings • May 01
Full year 2023 earnings released: AU$0.001 loss per share (vs AU$18.64 loss in FY 2022) Full year 2023 results: AU$0.001 loss per share (improved from AU$18.64 loss in FY 2022). Revenue: AU$1.66m (down 44% from FY 2022). Net loss: AU$2.02m (loss narrowed 80% from FY 2022). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Personal Products industry in Europe. New Risk • Apr 28
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (28% average weekly change). Earnings have declined by 60% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 39x increase in shares outstanding). Market cap is less than US$10m (€1.43m market cap, or US$1.53m). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Revenue is less than US$5m (AU$3.2m revenue, or US$2.1m). New Risk • Oct 18
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$2.0m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$2.0m free cash flow). Share price has been highly volatile over the past 3 months (34% average weekly change). Earnings have declined by 60% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 6x increase in shares outstanding). Market cap is less than US$10m (€482.9k market cap, or US$508.5k). Minor Risk Revenue is less than US$5m (AU$3.2m revenue, or US$2.1m). New Risk • Jun 29
New major risk - Financial position The company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (53% average weekly change). Earnings have declined by 56% per year over the past 5 years. Shareholders have been substantially diluted in the past year (162% increase in shares outstanding). Market cap is less than US$10m (€374.5k market cap, or US$408.8k). Minor Risk Revenue is less than US$5m (AU$3.0m revenue, or US$2.0m). Reported Earnings • Jun 29
Full year 2022 earnings released: AU$0.002 loss per share (vs AU$0.005 profit in FY 2021) Full year 2022 results: AU$0.002 loss per share (down from AU$0.005 profit in FY 2021). Revenue: AU$2.96m (down 1.5% from FY 2021). Net loss: AU$9.97m (down AU$10.2m from profit in FY 2021). Revenue is forecast to grow 7.9% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Personal Products industry in Europe. Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Director Shayne Kellow was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 05
First half 2022 earnings released: EPS: AU$0.007 (vs AU$0.009 in 1H 2021) First half 2022 results: EPS: AU$0.007. Revenue: AU$1.99m (up 42% from 1H 2021). Net income: AU$1.07m (up 196% from 1H 2021). Profit margin: 54% (up from 26% in 1H 2021). The increase in margin was primarily driven by higher revenue. Revenue is forecast to grow 8.9% p.a. on average during the next 3 years, compared to a 5.6% growth forecast for the Personal Products industry in Europe. Annuncio • May 31
Rapid Nutrition PLC (ENXTPA:ALRPD) acquired Silveraxe LLP for approximately USD 0.75 million. Rapid Nutrition PLC (ENXTPA:ALRPD) acquired Silveraxe LLP for approximately USD 0.75 million on May 30, 2022.
Rapid Nutrition PLC (ENXTPA:ALRPD) completed the acquisition of Silveraxe LLP on May 30, 2022. Annuncio • May 25
Rapid Nutrition PLC, Annual General Meeting, Jun 30, 2022 Rapid Nutrition PLC, Annual General Meeting, Jun 30, 2022, at 21:00 Coordinated Universal Time. Location: 2/40-46 Nestor Drive Meadowbrook, 4131 QLD, Logan Australia Agenda: To consider receiving the Company's annual accounts for the financial period ended 31 December 2021, together with the directors' report and the auditors' report on those accounts; to receive and approve the directors' remuneration report for the financial period ended 31 December 2021; to reappoint Elderton Audit UK (formerly known as Greenwich & Co UK) as auditors to hold office from the conclusion of this meeting until the conclusion of the next general meeting of the Company; to authorize the directors to fix the remuneration of the auditors; to reappoint Simon St Ledger as a director; to consider reappointing directors; and to consider such other matters. Buying Opportunity • May 11
Now 29% undervalued Over the last 90 days, the stock is up 141%. The fair value is estimated to be €0.075, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.7% over the last 3 years. Meanwhile, the company became loss making. Board Change • Apr 27
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Director Shayne Kellow was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Buying Opportunity • Mar 11
Now 27% undervalued after recent price drop Over the last 90 days, the stock is down 37%. The fair value is estimated to be AU$0.05, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.7% per annum over the last 3 years. The company became loss making over the last 3 years. Buying Opportunity • Feb 24
Now 26% undervalued after recent price drop Over the last 90 days, the stock is down 36%. The fair value is estimated to be AU$0.068, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.7% per annum over the last 3 years. The company became loss making over the last 3 years. Annuncio • Feb 09
Rapid Nutrition Announces New Distribution and Flavor Offerings Rapid Nutrition PLC has responded to increased demand for organic health and wellness offerings with new distribution and flavor offerings. Rapid Nutrition, a natural healthcare company focused on evidenced-based nutrition, diet management and life sciences products with growing worldwide distribution, is expanding its product offerings and continued growth in distribution, now sharing its organic health and wellness products throughout Australia, Asia, Europe, North America, EMEA as well as through its ecommerce channels. New brand extensions include: New mocha flavor for the popular high-protein meal replacements, which are also available in vanilla and chocolate. Coffee flavors continue to grow in popularity worldwide P.M. Protein Powder to curb late-night snacking urgers while also supporting a better night’s sleep. With 26 grams of protein per serving and a decadent Black Forest Cake flavor, this excellent source of protein and calcium caseinate includes enzymatically treated whey concentrate which results in a larger protein molecule that takes six hours longer to metabolize than typical whey protein. This allows for a slower release of aminos to support satiety and sleep. It also includes rutaecarpine, a botanical extract known as the anti-caffeine, to promote a sense of calm as well as tart cherry, a source of naturally occurring melatonin, and L-Theanine and L-Glutamine, amino acids that play an important role in sleep as precursors to sleep-inducing hormones. Two new bars added to the SystemLS range: Keto Cookie Dough Delight Whey Protein Bar and Keto Vegan Peanut Butter Brownie Plant Protein Bar. Both bars, formulated for Keto and high-protein diets, include high quality protein and are 100% natural with no artificial flavors or ingredients. The vegan bar and whey-based bar are designed to capture consumers interested in vegan products as well as those who prefer more traditional whey-based protein bars. New ingredients for the popular vegan proteins. Designed to further enhance the company’s popular vegan protein powders, include a new form of pea protein which has been fermented with mushrooms to enhance bioavailability and absorption and improve flavor while reducing GI disturbances. A customized blend of digestive enzymes eliminates the bloat that can accompany some high-protein products currently available on the market. In addition, these product updates and innovations all come with new-look sustainable packaging as part of Rapid Nutrition’s Corporate Social Responsibility commitments. 
